IMVT - Immunovant, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$43.67
DETAILS
HIGH:
$50.00
LOW:
$40.00
MEDIAN:
$41.00
CONSENSUS:
$43.67
UPSIDE:
27.88%
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.4 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 |
| Gross Profit | (0.4) | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 | 0 |
| Operating Expenses | |||||||||
| R&D Expenses | 456.7 | 360.9 | 212.9 | 160.3 | 101.8 | 68.6 | 47.9 | 25.7 | 135.3 |
| SG&A Expenses | 76.2 | 77.2 | 57.3 | 48.0 | 54.2 | 39.5 | 11.7 | 0.0 | 1.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 532.9 | 438.2 | 270.2 | 208.3 | 156.0 | 108.1 | 59.7 | 0.0 | 136.7 |
| Operating Income | |||||||||
| Operating Income | (532.9) | (438.2) | (270.2) | (208.3) | (156.0) | (108.1) | (59.7) | (0.0) | (136.7) |
| Interest Expense | 0 | 0 | 0 | 12.5 | – | 0 | 0.6 | 0 | 0 |
| Interest Income | 25.3 | 24.7 | 24.9 | 7.6 | – | 0 | 0.0 | 0 | 0 |
| Profitability | |||||||||
| EBITDA | (532.5) | (437.8) | (270.0) | (208.1) | (155.9) | (108.1) | (65.6) | 0.0 | 0 |
| EBIT | (532.9) | (438.2) | (270.2) | (208.3) | (156.0) | (108.1) | (65.7) | (0.0) | (136.7) |
| Income Before Tax | (505.4) | (412.9) | (258.8) | (211.0) | (156.8) | (107.8) | (66.3) | (0.0) | (136.7) |
| Income Tax Expense | 0.2 | 0.9 | 0.6 | 0.0 | (0.1) | (0.4) | 0.1 | 0 | 0 |
| Net Income | (505.6) | (413.8) | (259.3) | (211.0) | (156.7) | (107.4) | (66.4) | (0.0) | (136.7) |
| Per Share Data | |||||||||
| EPS (Basic) | -2.77 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 | – | -13.68 |
| EPS (Diluted) | -2.77 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 | – | -13.67 |
| Shares Outstanding | 182.4 | 151.6 | 138.1 | 123.1 | 109.7 | 87.8 | 43.2 | 14.4 | 10.0 |
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 902.1 | 714.0 | 635.4 | 376.5 | 493.8 | 400.1 | 100.6 | 0.3 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 3.9 | 2.5 | 5.5 | 0.9 | 12.9 | 1.1 | 3.0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 42.8 | 51.2 | 24.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 948.8 | 767.7 | 665.8 | 404.3 | 512.9 | 409.0 | 109.1 | 0.3 | 0.1 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 0.5 | 0.9 | 0.6 | 1.5 | 2.6 | 3.5 | 0.1 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 7.7 | 7.6 | 0 | 0 | 0 | 0 | 0.2 | 0.1 | 0 |
| Total Non-Current Assets | 8.7 | 8.6 | 0.9 | 1.5 | 2.6 | 3.5 | 0.3 | 0.1 | 0 |
| Total Assets | 957.6 | 776.2 | 666.7 | 405.8 | 515.6 | 412.5 | 109.4 | 0.4 | 0.1 |
| Current Liabilities | |||||||||
| Account Payables | 7.5 | 17.7 | 7.2 | 1.4 | 18.6 | 2.4 | 1.2 | 0 | 1.1 |
| Short-Term Debt | 0.1 | 0 | 0.1 | 0 | 0 | 0 | 3.2 | 0.3 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 |
| Other Current Liabilities | 80.0 | 15.6 | 26.6 | 0.3 | 0.2 | 3.1 | 10.9 | (0.0) | 0 |
| Total Current Liabilities | 104.4 | 68.8 | 48.6 | 43.3 | 44.5 | 18.8 | 15.3 | 0.4 | 1.6 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0.6 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 0.6 | 0 | 0.3 | 0.0 | 1.2 | 2.2 | 0 | 0.3 | 0 |
| Total Liabilities | 105.0 | 68.8 | 49.0 | 43.3 | 45.7 | 21.0 | 15.3 | 0.4 | 1.6 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 |
| Retained Earnings | (1,745.1) | (1,239.5) | (825.7) | (566.3) | (355.4) | (198.7) | (91.2) | (0.0) | 0 |
| Accumulated Other Comprehensive Income | 0.7 | 1.5 | 1.9 | 0.9 | 0.4 | (0.3) | (0.0) | 0.3 | (1.5) |
| Total Stockholders' Equity | 852.6 | 707.4 | 617.8 | 362.5 | 469.8 | 391.5 | 94.1 | 0.0 | (1.5) |
| Total Liabilities & Equity | 957.6 | 776.2 | 666.7 | 405.8 | 515.6 | 412.5 | 109.4 | 0.4 | 0.1 |
| Debt Metrics | |||||||||
| Total Debt | 0.1 | 0.1 | 0.1 | 1.2 | 2.4 | 3.4 | 3.2 | 0.3 | 0 |
| Net Debt | (902.0) | (713.9) | (635.2) | (375.3) | (491.5) | (396.7) | (97.4) | (0.0) | 0 |
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (505.6) | (413.8) | (259.3) | (211.0) | (156.7) | (107.4) | (66.4) | (28.6) | (136.7) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.2 | 0.2 | 0.1 | 1.0 | 0.0 | 0.0 | 0 |
| Stock-Based Compensation | 55.7 | 49.5 | 41.1 | 32.3 | 34.2 | 0 | 7.0 | 1.3 | 1.8 |
| Change in Working Capital | 42.1 | (12.0) | 2.6 | (10.9) | 15.1 | 4.6 | 4.8 | (0.5) | 1.4 |
| Other Non-Cash Items | 0.1 | 0.1 | 1.1 | 1.1 | 1.1 | 18.5 | 1.2 | (0.8) | 5.2 |
| Operating Cash Flow | (407.3) | (375.9) | (214.2) | (188.2) | (106.1) | (83.3) | (53.4) | (28.5) | (128.3) |
| Investing Activities | |||||||||
| Capital Expenditure | (0.0) | (0.8) | (0.4) | (0.2) | (0.3) | (0.2) | (0.0) | (0.1) | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (0.0) | (0.8) | (0.4) | (0.2) | (0.3) | (0.2) | (0.0) | (0.1) | 0 |
| Financing Activities | |||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | (3.2) | 37.9 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.5) | 4.5 | (0.3) | 0.4 | 200.1 | 0 | 109.1 | 35.6 | 128.3 |
| Financing Cash Flow | 595.8 | 454.5 | 472.4 | 70.9 | 200.1 | 383.1 | 147.0 | 35.6 | 128.3 |
| Cash Position | |||||||||
| Net Change in Cash | 188.1 | 78.6 | 258.8 | (117.3) | 93.7 | 299.6 | 93.6 | 7.0 | 0 |
| Cash at Beginning | 714.0 | 635.4 | 376.5 | 493.8 | 400.1 | 100.6 | 7.0 | 0 | 0 |
| Cash at End | 902.1 | 714.0 | 635.4 | 376.5 | 493.8 | 400.1 | 100.6 | 7.0 | 0 |
| Free Cash Flow | (407.3) | (376.6) | (214.6) | (188.4) | (106.4) | (83.5) | (53.4) | (28.6) | (128.3) |
| Key Metrics | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.4) | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 | 0 |
| Operating Income | (532.9) | (438.2) | (270.2) | (208.3) | (156.0) | (108.1) | (59.7) | (0.0) | (136.7) |
| Net Income | (505.6) | (413.8) | (259.3) | (211.0) | (156.7) | (107.4) | (66.4) | (0.0) | (136.7) |
| EPS (Diluted) | -2.77 | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 | – | -13.67 |
| Balance Sheet | |||||||||
| Cash & Equivalents | 902.1 | 714.0 | 635.4 | 376.5 | 493.8 | 400.1 | 100.6 | 0.3 | 0 |
| Total Assets | 957.6 | 776.2 | 666.7 | 405.8 | 515.6 | 412.5 | 109.4 | 0.4 | 0.1 |
| Total Debt | 0.1 | 0.1 | 0.1 | 1.2 | 2.4 | 3.4 | 3.2 | 0.3 | 0 |
| Stockholders' Equity | 852.6 | 707.4 | 617.8 | 362.5 | 469.8 | 391.5 | 94.1 | 0.0 | (1.5) |
| Cash Flow | |||||||||
| Operating Cash Flow | (407.3) | (375.9) | (214.2) | (188.2) | (106.1) | (83.3) | (53.4) | (28.5) | (128.3) |
| Capital Expenditure | (0.0) | (0.8) | (0.4) | (0.2) | (0.3) | (0.2) | (0.0) | (0.1) | 0 |
| Free Cash Flow | (407.3) | (376.6) | (214.6) | (188.4) | (106.4) | (83.5) | (53.4) | (28.6) | (128.3) |